A Clinical program is only complete with diagnostic facilities in determination of diseases with medicine supplements in completing treatments post diagnosis. The Aarogya Vahini team extends its services through periodic monitoring , follow ups and logistic support for referral treatments
A key component of an inclusive wellness and healthcare program is the Community pharmacy. With a competent pharmacist team and support of major Pharmaceutical organizations, the trust has been able address to more than 15000 chronic patients month on month since 2018. The above support has had a significant impact on the beneficiaries with the sustained support in reducing not only their monthly expenses towards medicines but in controlling their vital indexs’ and measurable parameters for Cardiovascular & glucose levels reducing the probability of tertiary diseases.
The pharma division has touch over 53068 beneficiaries over the years , where every month the addition of chronic patients in Hypertensive - 7100, Diabetes Type II - 6700 and both Hypertensive & Diabetes - 1100 cumulatively adds to around 14900 patients who avail and gets benefitted month on month from the pharma along with the other diversified requirements of medicine.
A dedicated efforts towards control of Diabetes was on of the key focus of the program : The primary symptoms looked for were
- In Type 1 diabetes, the classic symptoms are excessive secretion of urine (polyuria), thirst (polydipsia), weight loss and tiredness.
- These symptoms may be less marked in Type 2 diabetes. In this form, it can also happen that no early symptoms appear and the disease is only diagnosed several years after its onset, when complications are already present
Diabetes in pregnancy also give rises to several adverse outcomes, including congenital malformations, increased birth weight and an elevated risk of perinatal mortality. Strict metabolic control may reduce these risks to the level of those of non-diabetic expectant mothers.
The Detection & Confirmation Methods Followed in the Program:
1st Level Screening: Patients with RBS 140 mg/dl are suspected to diabetic patient.
2nd Level Screening: Patients with FBS > 126 mg/dl or RBS > 200 mg/dl are screened as diabetic patient.
3rd Level Screening: Patients with HbA1c > 6.5 are screened as diabetic patient.
4th Level Screening: Patients with RBS > 350 mg/dl are immediately refer to District Hospital.